פירדפסה 以色列 - 希伯来文 - Ministry of Health

פירדפסה

medison pharma ltd - amifampridine - טבליה - amifampridine 10 mg - amifampridine

קלפרופן 10% וטרינרי 以色列 - 希伯来文 - Ministry of Health

קלפרופן 10% וטרינרי

romat ltd - ketoprofen - תמיסה להזרקה - ketoprofen 100 mg / 1 ml

פולמוזיים 以色列 - 希伯来文 - Ministry of Health

פולמוזיים

roche pharmaceuticals (israel) ltd - recombinant human deoxyribonuclease - תמיסה לשאיפה - recombinant human deoxyribonuclease 1 mg/ml - dornase alfa (desoxyribonuclease) - dornase alfa (desoxyribonuclease) - management of cystic fibrosis not for patients under 5 years of age or with fvc<40% .

פלודרה 以色列 - 希伯来文 - Ministry of Health

פלודרה

sanofi - aventis israel ltd - fludarabine phosphate 50 mg/vial - powder for solution for inj/inf - fludarabine - palliative treatment of patients with cll refractory to other therapy. treatment of less malignant non-hodgkin lymphoma of stage 3 to 4 in patients who have not responded to standard therapy with at least one alkylating agent or in whom the disease progressed during or after standard therapy. fludara is indicated for the initial treatment of patients with b- cell chronic lymphocytic leukaemia (cll) or after first line therapy, in patients with sufficient bone marrow reserves.

אוולטרה  以色列 - 希伯来文 - Ministry of Health

אוולטרה

sanofi israel ltd - clofarabine - תרכיז להכנת תמיסה לאינפוזיה - clofarabine 1 mg/ml - clofarabine - clofarabine - treatment of acute lymphoblastic leukaemia (all) in paediatric patients who have relapsed or are refractory after receiving at least two prior regimens and who are about to undergo transplantation. safety and efficacy have been assessed in studies of patients < or = 21 years old at initial diagnosis .

אוולטרה ® 以色列 - 希伯来文 - Ministry of Health

אוולטרה ®

sanofi - aventis israel ltd - clofarabine 1 mg/ml - concentrate for solution for infusion - clofarabine - treatment of acute lymphoblastic leukaemia (all) in paediatric patients who have relapsed or are refractory after receiving at least two prior regimens and who are about to undergo transplantation. safety and efficacy have been assessed in studies of patients < or = 21 years old at initial diagnosis .

מוזוביל 以色列 - 希伯来文 - Ministry of Health

מוזוביל

sanofi - aventis israel ltd - plerixafor 24 mg / 1.2 ml - solution for injection - plerixafor - mozobil is indicated in combination with g-csf to enhance mobilisation of haematopietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with lymphoma and multiple myeloma .

טימוגלובולין 以色列 - 希伯来文 - Ministry of Health

טימוגלובולין

sanofi israel ltd - immunoglobulin rabbit anti-human thymocyte - אבקה להכנת תמיסה מרוכזת לעירוי - immunoglobulin rabbit anti-human thymocyte 25 mg/vial - antithymocyte immunoglobulin (rabbit) - antithymocyte immunoglobulin (rabbit) - immunosuppression in transplantation: prevention and treatment of graft rejection. treatment of acute graft versus host disease (gvhd). hematology treatment of aplastic anemia.

רנג'ל טבליות 800 מ"ג 以色列 - 希伯来文 - Ministry of Health

רנג'ל טבליות 800 מ"ג

sanofi - aventis israel ltd - sevelamer hydrochloride 800 mg - film coated tablets - sevelamer - reduction of serum phosphorus in patients with end stage renal disease ( esrd) . the safety and efficacy of renagel in esrd patients who are not on hemodialysis have not been studied. in hemodialysis patients renagel decreases the incidence of hypercalcemic episodes relative to patients on calcium acetate treatment.

תירוג'ן 以色列 - 希伯来文 - Ministry of Health

תירוג'ן

sanofi israel ltd - thyrotropin alfa - אבקה להכנת תמיסה לזריקה - thyrotropin alfa 0.9 mg/ml - thyrotropin - thyrotropin - adjunctive diagnostic tool for serum thyroglobulin (tg) testing with or without radioiodine imaging in the followup of patients with well-differentiated thyroid cancer.adjunctive treatment for radioiodine ablation of thyroid tissue remnants in patients who have undergone a near-total or total thyroidectomy for well differentiated thyroid cancer and who do not have evidence of metastatic thyroid cancer.